Skip to main content
Decorative image for Follow Our Progress page banner

Follow Our Progress

Company NewsPresentations

RAG-17, a Novel siRNA Therapy for SOD1-ALS: Safety and Preliminary Efficacy from a First-in-human Trial (Abstract)

By April 9, 2025November 5th, 2025No Comments
PUBLICATIONS & PRESENTATIONS

RAG-17, a Novel siRNA Therapy for SOD1-ALS: Safety and Preliminary Efficacy from a First-in-human Trial (Abstract)